ILARIA COLOMBO
Suíça
Dr Ilaria Colombo is a medical oncologist specialized in the treatment of gynaecological malignancies and in early phase clinical trials for solid tumors.
She graduated in Medicine at University of Milan, Italy where she also obtained a post-graduate degree in Medical Oncology. In 2014, she obtained a master’s degree in 'Methodology of Clinical Research’ from the University of Parma, Italy.
After establishing her clinical expertise in Italy, she improved her skills in clinical research at the Princess Margaret Cancer Centre, Toronto, Canada focusing on new drugs development and translation research for gynecological malignancies.
Currently, she is the disease site lead for gynecological cancers at the Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH and a senior physician at the New Drugs Development Unit. Since 2023 she has been appointed as co-chair of the IOSI Clinical Research Unit. She is involved as Principal and Co-Investigator in many national and international clinical trials.
She is a Faculty Member of the ESMO Gynaecological Group and Vice-president of the Gynaecological Project Group of the Swiss Group for Clinical Cancer Research (SAKK). More recently, she has been selected for the ESMO Leaders Generation Program 2023-2024.
Suíça
Dr Ilaria Colombo is a medical oncologist specialized in the treatment of gynaecological malignancies and in early phase clinical trials for solid tumors.
She graduated in Medicine at University of Milan, Italy where she also obtained a post-graduate degree in Medical Oncology. In 2014, she obtained a master’s degree in 'Methodology of Clinical Research’ from the University of Parma, Italy.
After establishing her clinical expertise in Italy, she improved her skills in clinical research at the Princess Margaret Cancer Centre, Toronto, Canada focusing on new drugs development and translation research for gynecological malignancies.
Currently, she is the disease site lead for gynecological cancers at the Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH and a senior physician at the New Drugs Development Unit. Since 2023 she has been appointed as co-chair of the IOSI Clinical Research Unit. She is involved as Principal and Co-Investigator in many national and international clinical trials.
She is a Faculty Member of the ESMO Gynaecological Group and Vice-president of the Gynaecological Project Group of the Swiss Group for Clinical Cancer Research (SAKK). More recently, she has been selected for the ESMO Leaders Generation Program 2023-2024.